Literature DB >> 14700112

Appropriateness of gastric antisecretory therapy in hospital practice.

S S Sebastian1, N Kernan, A Qasim, C A O'Morain, M Buckley.   

Abstract

BACKGROUND: Recent data indicate an exponential increase in proton pump inhibitor (PPI) prescribing, and concerns are raised regarding the appropriateness of these prescriptions and the financial implications. AIM: To survey the appropriateness of PPI prescription in a cohort of patients in a tertiary referral hospital.
METHODS: Prescription records of all inpatients on a randomly selected day were reviewed. The appropriateness of prescription and relevant investigations were identified by interview of patients, review of patient records and of a computerised endoscopy records system.
RESULTS: Thirty-two per cent (87 of 272) of all patients were on PPIs. A valid indication for therapy was not apparent in 63% of the patients on PPIs with the only predictive factor for inappropriate prescription being increasing age. Only 36 of the 87 patients on PPIs had undergone appropriate investigations for their gastrointestinal symptoms. Gender, age, speciality of admission or duration of hospital stay did not influence the appropriateness of prescription or performance of relevant investigations.
CONCLUSION: There appears to be a widespread and inappropriate use of PPIs in hospital practice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14700112     DOI: 10.1007/bf02914494

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  18 in total

1.  Sleeping with the enemy? A randomized controlled trial of a collaborative health authority/industry intervention to influence prescribing practice.

Authors:  N Freemantle; R Johnson; J Dennis; A Kennedy; M Marchment
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

2.  Increasing concerns about chronic proton pump inhibitor use.

Authors:  A C Svoboda
Journal:  J Clin Gastroenterol       Date:  2001-07       Impact factor: 3.062

3.  Proton pump inhibitors: a study of GPs' prescribing.

Authors:  M I Jones; S M Greenfield; S Jowett; C P Bradley; R Seal
Journal:  Fam Pract       Date:  2001-06       Impact factor: 2.267

4.  Proton-pump inhibitors: three of a kind?

Authors:  D N Bateman
Journal:  Lancet       Date:  1997-06-07       Impact factor: 79.321

5.  Concordance between use of proton pump inhibitors and prescribing guidelines.

Authors:  P I Pillans; P A Kubler; J M Radford; V Overland
Journal:  Med J Aust       Date:  2000-01-03       Impact factor: 7.738

6.  Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer.

Authors:  T C Wang; C A Dangler; D Chen; J R Goldenring; T Koh; R Raychowdhury; R J Coffey; S Ito; A Varro; G J Dockray; J G Fox
Journal:  Gastroenterology       Date:  2000-01       Impact factor: 22.682

7.  Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database.

Authors:  J N Bashford; J Norwood; S R Chapman
Journal:  BMJ       Date:  1998-08-15

8.  Antiulcer drug prescribing in hospital successfully influenced by "immediate concurrent feedback".

Authors:  C R Kumana; T Y Ching; E Cheung; Y Kong; M Kou; C K Chan; K M Chu; W H Seto; S K Lam
Journal:  Clin Pharmacol Ther       Date:  1998-11       Impact factor: 6.875

9.  Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy.

Authors:  M G Bramble; Z Suvakovic; A P Hungin
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

10.  An intervention on discharge polypharmacy.

Authors:  D M Smith; M R Cox; E J Brizendine; S L Hui; J A Freedman; D K Martin; M D murray
Journal:  J Am Geriatr Soc       Date:  1996-04       Impact factor: 5.562

View more
  7 in total

1.  Inadequate use of acid-suppressive therapy in hospitalized patients and its implications for general practice.

Authors:  Raffaella Scagliarini; Elena Magnani; Antonino Praticò; Renato Bocchini; Paola Sambo; Paolo Pazzi
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

2.  Inappropriate use of proton pump inhibitors.

Authors:  D Molloy; A Molloy; C O'Loughlin; M Falconer; M Hennessy
Journal:  Ir J Med Sci       Date:  2009-09-11       Impact factor: 1.568

Review 3.  A benefit-risk assessment of the use of proton pump inhibitors in the elderly.

Authors:  Gwen M C Masclee; Miriam C J M Sturkenboom; Ernst J Kuipers
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

4.  Physicians' opinions of stress ulcer prophylaxis: survey results from a large urban medical center.

Authors:  Charles P Koczka; Laura B Geraldino-Pardilla; Adam J Goodman
Journal:  Dig Dis Sci       Date:  2012-10-12       Impact factor: 3.199

5.  Unexplained abdominal pain as a driver for inappropriate therapeutics: an audit on the use of intravenous proton pump inhibitors.

Authors:  Pauline Siew Mei Lai; Yin Yen Wong; Yong Chia Low; Hui Ling Lau; Kin-Fah Chin; Sanjiv Mahadeva
Journal:  PeerJ       Date:  2014-06-26       Impact factor: 2.984

Review 6.  Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.

Authors:  Anca Trifan; Carol Stanciu; Irina Girleanu; Oana Cristina Stoica; Ana Maria Singeap; Roxana Maxim; Stefan Andrei Chiriac; Alin Ciobica; Lucian Boiculese
Journal:  World J Gastroenterol       Date:  2017-09-21       Impact factor: 5.742

7.  Inappropriate use of proton pump inhibitors among medical inpatients: a questionnaire-based observational study.

Authors:  Muhammad Haroon; Faiza Yasin; Syed K M Gardezi; Fahd Adeeb; Frank Walker
Journal:  JRSM Short Rep       Date:  2013-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.